ELAB PMGC HOLDINGS INC.

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

NEWPORT BEACH, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-6 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 12:00 am, Eastern time, on March 10, 2026.

Key Details of the Reverse Stock Split:

  • Conversion Ratio: Every 6 shares of issued and outstanding Common Stock will be consolidated into one share of Common Stock, and every 6 shares of authorized Common Stock will be consolidated into one share of Common Stock, each with no further action required from shareholders.
  • Fractional Shares: Shareholders entitled to fractional shares will receive one full share for each fractional portion.
  • Updated Stock Identifier: While the trading symbol for the Common Stock will remain “ELAB,” the Common Stock will be designated a new CUSIP number 73017P508.
  • Equity Adjustments: Outstanding stock awards, options, and the shares reserved for the equity incentive plan will be adjusted proportionally to reflect the Split.
  • Warrant Share and Exercise Price Adjustments: Shares of Common Stock underlying outstanding warrants and the exercise price of the outstanding warrants will be adjusted proportionally to reflect this stock split.

Impact on Shareholders:

  • Certificate Holders: Shareholders with physical certificates can exchange them, if desired, through VStock Transfer, LLC, the transfer agent of the Company, which will provide detailed instructions.
  • Share Value: The reverse split does not impact the overall value of shareholder equity; it only reduces the number of shares outstanding while proportionally adjusting the share price.

Impact on our Common Stock:

The Company anticipates that there will be approximately 541,461 shares of common stock issued and outstanding immediately following the anticipated reverse stock split on March 10, 2026. The Company anticipates that there will be approximately 3,248,764 shares of common stock issued and outstanding immediately prior to the anticipated reverse stock split on March 10, 2026.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,” “would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC Holdings’ filings with the United States Securities and Exchange Commission (“SEC”), including the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 28, 2025, and its other documents subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at . All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

IR Contact:



EN
04/03/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PMGC HOLDINGS INC.

 PRESS RELEASE

PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and File...

PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024 Deploys Capital into Cash-Flowing Manufacturing Businesses in Aerospace, Defense and IT PackagingAdvances Dual Myostatin Assets Targeting Muscle Preservation in Potential Combination with GLP-1 Treatments NEWPORT BEACH, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“the Company,” “PMGC,” “we,” or “our”) today filed its Annual Report on Form 10-K (“Annual Report”) for the fiscal year ended December 31, 2025 (“FYE ...

 PRESS RELEASE

NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA L...

NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 Treatments NEWPORT BEACH, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc.’s (NASDAQ: ELAB) (“PMGC,” “we,” or “our”) wholly owned subsidiary, NorthStrive Biosciences Inc. (“Northstrive Biosciences”), announced today a third amendment (“Amendment”) to its existing License Agreement with MOA Life Plus Co., Ltd., [KOSDAQ: 142760] a Korean biotechnology company (“MOA,” and such existing agreement, as amen...

 PRESS RELEASE

SVM Machining, Inc. Secures ITAR Registration, Enabling Entry into U.S...

SVM Machining, Inc. Secures ITAR Registration, Enabling Entry into U.S. Defense Manufacturing Contracts NEWPORT BEACH, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: PMGC) (“PMGC” or the “Company”), a diversified public holding company executing a targeted roll-up strategy in U.S.-based manufacturing, is pleased to announce that its wholly owned subsidiary, SVM Machining, Inc. dba Silicon Valley Manufacturing (“SVM”), has completed International Traffic in Arms Regulations (“ITAR”) registration and is in compliance with ITAR. The ITAR is administered by the U.S. St...

 PRESS RELEASE

NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Ev...

NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss Therapy NEWPORT BEACH, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”) today announced the initiation of a preclinical study for EL-32, an engineered probiotic candidate being developed by its wholly owned subsidiary, NorthStrive Biosciences Inc. (“NorthStrive Biosciences”). The study is designed to evaluate EL-32’s potential to preserve lean muscle mass while promoting fat loss, both as a standalone therapy and in c...

 PRESS RELEASE

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split NEWPORT BEACH, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-6 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 12:00 am, Eastern time, on March 10, 2026. Key Details of the Reverse Stock Split: Conversion Ratio: Every 6 shares of issued and outstanding Common Stock will be consolidated into one share of Common Stock, and ever...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch